Identifying severe bacterial infection in children with fever without source

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 11, 2010, Pages 1231-1237

  Galetto Lacour, Annick ^a   Gervaix, Alain ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

C reactive protein; clinical decision rules; fever without source; pediatrics; procalcitonin; severe bacterial infections

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN;

AGE; BACTERIAL INFECTION; CHILD; CHILD CARE; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL FEATURE; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEVER; HUMAN; INFECTION RISK; LABORATORY DIAGNOSIS; NEUTROPHIL COUNT; PREDICTION; PROTEIN FUNCTION; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TEMPERATURE MEASUREMENT; TOTAL QUALITY MANAGEMENT; URINALYSIS;

BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DIAGNOSIS, DIFFERENTIAL; FEVER OF UNKNOWN ORIGIN; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTE COUNT; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEPSIS; VIRUS DISEASES;

EID: 78349250602     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.118     Document Type: Review

References (50)

1. Thayyil S, Shenoy M, Hamaluba M, Gupta A, Frater J, Verber IG. Is procalcitonin useful in early diagnosis of serious bacterial infections in children? Acta Paediatr. 94(2), 155-158 (2005).
2. Andreola B, Bressan S, Callegaro S, Liverani A, Plebani M, Da Dalt L. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr. Infect. Dis. J. 26(8), 672-677 (2007).
3. Pratt A, Attia MW. Duration of fever and markers of serious bacterial infection in young febrile children. Pediatr. Int. 49(1), 31-35 (2007).
4. Galetto-Lacour A, Gervaix A, Zamora SA et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identifcators of serious bacterial infections in children with fever without localising signs. Eur. J. Pediatr. 160(2), 95-100 (2001).
5. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 112(5), 1054-1060 (2003).
6. Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics 108(6), 1275-1279 (2001).
7. Isaacman DJ, Burke BL. Utility of the serum C-reactive protein for detection of occult bacterial infection in children. Arch. Pediatr. Adolesc. Med. 156(9), 905-909 (2002).
8. Hoberman A, Wald ER. Urinary tract infections in young febrile children. Pediatr. Infect. Dis. J. 16(1), 11-17 (1997).
9. Hoberman A, Chao HP, Keller DM, Hickey R, Davis HW, Ellis D. Prevalence of urinary tract infection in febrile infants. J. Pediatr. 123(1), 17-23 (1993). (Pubitemid 23185192)
10. Shaw KN, Gorelick M, McGowan KL, Yakscoe NM, Schwartz JS. Prevalence of urinary tract infection in febrile young children in the emergency department. Pediatrics 102(2), e16 (1998).
11. Taylor JA, Del Beccaro M, Done S, Winters W. Establishing clinically relevant standards for tachypnea in febrile children younger than 2 years. Arch. Pediatr. Adolesc. Med. 149(3), 283-287 (1995).
12. Murphy CG, van de Pol AC, Harper MB, Bachur RG. Clinical predictors of occult pneumonia in the febrile child. Acad. Emerg. Med. 14(3), 243-249 (2007).
13. Fleisher GR, Rosenberg N, Vinci R et al. Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia. J. Pediatr. 124(4), 504-512 (1994).
14. Jaffe DM, Tanz RR, Davis AT, Henretig F, Fleisher G. Antibiotic administration to treat possible occult bacteremia in febrile children. N. Engl. J. Med. 317(19), 1175-1180 (1987).
15. Kuppermann N, Fleisher GR, Jaffe DM. Predictors of occult pneumococcal bacteremia in young febrile children. Ann. Emerg. Med. 31(6), 679-687 (1998).
16. Stoll ML, Rubin LG. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center. Arch. Pediatr. Adolesc. Med. 158(7), 671-675 (2004).
17. Herz AM, Greenhow TL, Alcantara J et al. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr. Infect. Dis. J. 25(4), 293-300 (2006).
18. Eagles D, Stiell IG, Clement CM et al. International survey of emergency physicians' priorities for clinical decision rules. Acad. Emerg. Med. 15(2), 177-182 (2008).
19. Bonadio WA, Hennes H, Smith D et al. Reliability of observation variables in distinguishing infectious outcome of febrile young infants. Pediatr. Infect. Dis. J. 12(2), 111-114 (1993).
20. McCarthy PL, Sharpe MR, Spiesel SZ et al. Observation scales to identify serious illness in febrile children. Pediatrics 70(5), 802-809 (1982).
21. Hewson P, Poulakis Z, Jarman F et al. Clinical markers of serious illness in young infants: a multicentre follow-up study. J. Paediatr. Child. Health. 36(3), 221-225 (2000).
22. Fernandez Lopez A, Luaces Cubells C, Garcia Garcia JJ, Fernandez Pou J. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr. Infect. Dis. J. 22(10), 895-903 (2003).
23. Van Den Bruel A, Haj-Hassan T, Thompson M, Buntinx F, Mant D. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet 375 (9717), 834-845 (2010).
24. Craig JC, Williams GJ, Jones M et al The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15 781 febrile illnesses. BMJ 340, c1594 (2010).
25. Thompson M, Coad N, Harnden A, Mayon-White R, Perera R, Mant D. How well do vital signs identify children with serious infections in paediatric emergency care? Arch. Dis. Child. 94(11), 888-893 (2009).
26. van Veen M, Steyerberg EW, Ruige M et al. Manchester triage system in paediatric emergency care: prospective observational study. BMJ 337, a1501 (2008).
27. Kuppermann N. Occult bacteremia in young febrile children. Pediatr. Clin. North Am. 46(6), 1073-1109 (1999).
28. Baraff LJ, Bass JW, Fleisher GR et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann. Emerg. Med. 22(7), 1198-1210 (1993).
29. Baraff LJ. Management of fever without source in infants and children. Ann. Emerg. Med. 36(6), 602-614 (2000).
30. American College of Emergency Physicians Clinical Policies Committee; American College of Emergency Physicians Clinical Policies Subcommittee on Pediatric Fever. Clinical policy for children younger than three years presenting to the emergency department with fever. Ann. Emerg. Med. 42(4), 530-545 (2003).
31. Ishimine P. Fever without source in children 0 to 36 months of age. Pediatr. Clin. North Am. 53(2), 167-194 (2006).
32. Ishimine P. The evolving approach to the young child who has fever and no obvious source. Emerg. Med. Clin. North Am. 25(4), 1087-1115, vii (2007).
33. Bonsu BK, Chb M, Harper MB. Identifying febrile young infants with bacteremia: is the peripheral white blood cell count an accurate screen? Ann. Emerg. Med. 42(2), 216-225 (2003).
34. Berger RM, Berger MY, van Steensel-Moll HA, Dzoljic-Danilovic G, Derksen-Lubsen G. A predictive model to estimate the risk of serious bacterial infections in febrile infants. Eur. J. Pediatr. 155(6), 468-473 (1996).
35. Sanders S, Barnett A, Correa-Velez I, Coulthard M, Doust J. Systematic review of the diagnostic accuracy of C-reactive protein to detect bacterial infection in nonhospitalized infants and children with fever. J. Pediatr. 153(4), 570-574 (2008).
36. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341(8844), 515-518 (1993).
37. Dandona P, Nix D, Wilson MF et al. Procalcitonin increase after endotoxin injection in normal subjects. J. Clin. Endocrinol. Metab. 79(6), 1605-1608 (1994).
38. Lacour AG, Zamora SA, Gervaix A. A score identifying serious bacterial infections in children with fever without source. Pediatr. Infect. Dis. J. 27(7), 654-656 (2008).
39. Sackett D, Haynes R, Guyatt G, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. Lippincott Williams and Wilkins, Boston, MA, USA (1991).
40. Olaciregui I, Hernandez U, Munoz JA, Emparanza JI, Landa JJ. Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin. Arch. Dis. Child. 94(7), 501-505 (2009).
41. Schwartz S, Raveh D, Toker O, Segal G, Godovitch N, Schlesinger Y. A week-by-week analysis of the low-risk criteria for serious bacterial infection in febrile neonates. Arch. Dis. Child. 94(4), 287-292 (2009).
42. Maniaci V, Dauber A, Weiss S, Nylen E, Becker KL, Bachur R. Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics 122(4), 701-710 (2008).
43. Hsiao AL, Chen L, Baker MD. Incidence and predictors of serious bacterial infections among 57- to 180-day-old infants. Pediatrics 117(5), 1695-1701 (2006).
44. Bressan S, Andreola B, Cattelan F, Zangardi T, Perilongo G, Da Dalt L. Predicting severe bacterial infections in well-appearing febrile neonates: laboratory markers accuracy and duration of fever. Pediatr. Infect. Dis. J. 29(3), 227-232 (2010).
45. Guyatt GH, Haynes RB, Jaeschke RZ et al. Users' Guides to the Medical Literature: XXV. Evidence-based medicine: principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group. JAMA 284(10), 1290-1296 (2000).
46. Bachur RG, Harper MB. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics 108(2), 311-316 (2001).
47. Isaacman DJ, Shults J, Gross TK, Davis PH, Harper M. Predictors of bacteremia in febrile children 3 to 36 months of age. Pediatrics 106(5), 977-982 (2000).
48. Bleeker SE, Moons KG, Derksen-Lubsen G, Grobbee DE, Moll HA. Predicting serious bacterial infection in young children with fever without apparent source. Acta Paediatr. 90(11), 1226-1232 (2001).
49. Bleeker SE, Derksen-Lubsen G, Grobbee DE, Donders AR, Moons KG, Moll HA. Validating and updating a prediction rule for serious bacterial infection in patients with fever without source. Acta Paediatr. 96(1), 100-104 (2007).
50. Galetto-Lacour A, Zamora SA, Andreola B et al. Validation of a laboratory risk index score for the identifcation of severe bacterial infection in children with fever without source. Arch. Dis. Child. DOI:10.1136/adc.2009. 176800 (2010) (Epub ahead of print).